Inventor
HAMON SARA
US5 patents
Patents
5 patentsUS12571027B2Mar 10, 2026
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
REGENERON PHARMA0 citations56
US12116622B2Oct 15, 2024
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
REGENERON PHARMA0 citations56
US11769597B2Sep 26, 2023
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
REGENERON PHARMA0 citations56
US11519020B2Dec 6, 2022
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
REGENERON PHARMA0 citations56
US12310717B2May 27, 2025
Gait analysis system
REGENERON PHARMA0 citations34